can retatrutide cause cancer Long-Term Side Effects: What Current Trial Data Show – Bolt Pharmacy Incretin triple agonist retatrutide (LY3437943)

Additionally, it has been reported that certain oral health risks are associated with using Ozempic, including halitosis, dry mouth, and changes in taste (Bando 18)

Are you paying for brand/marketing

I was worried that the data would show some red flags, such as an increase in stroke risk

31,44 Indeed, a network meta-analysis of randomized controlled trials of GLP-1 receptor agonists in patients with T2D noted significant decreases in fat-free mass

[14] [15] Prescribers should refer to the FDA Prescribing Information for Egrifta/Egrifta SV for full contraindication and monitoring guidance, as no UK SmPC exists

Experiences vary